13..A data-driven approach to classifying daily continuous glucose monitoring (CGM) time series
48.Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
56.Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study
59. Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
111.Hemoperfusion in patients with severe COVID‑19 respiratory failure, lifesaving or not?